Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-500-6 | CAS number: 96-33-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
Methyl acrylate is readily absorbed by the oral, dermal and inhalation routes and the major portion is rapidly (1) hydrolyzed by carboxyesterases to acrylic acid and methanol and/or (2) conjugated with glutathione. In vivo, greater than 90 % is excreted within 72 hours, primarily via the lungs (> 50 %) as CO2, and kidneys (40-50 %) as products of methyl acrylate-glutathione conjugation. In vitro tests using rat liver microsomes, Methyl Acrylate hydrolyzed to form the metabolite acrylic acid (AA) with a half-life of less than 8.5 minutes. In whole rat blood in vitro, MA quickly metabolized, shown by a significant and (nearly) complete loss of the parent acrylate. Based on the measured concentrations of the remaning parent acrylate, the half-life value for MA was less than 12 minutes in rat blood. MA formed a single GSH conjugate in the presence of GST.
Dermal absorption is somewhat slower and appears to follow irritation of the skin, possibly reflecting an initial de-esterification, with subsequent absorption of the acrylic acid formed.
Discussion on bioaccumulation potential result:
Methyl acrylate is rapidly absorbed by the oral and inhalation routes and distributed throughout the body. After oral or intraperitoneal administration, greater than 90 % is excreted within 72 hours, primarily via the lungs as carbon dioxide (> 50 %), and kidneys as products of glutathione conjugation reactions (10-50 %) (Delbressine 1981, Sapota 1988 & 1990, Seutter 1981). The predominant pathway of metabolism of methyl acrylate, by many tissues (including lung, liver, kidney and plasma) appears to be hydrolysis to acrylic acid and methanol, which is catalyzed by carboxyl esterase enzymes. Thus, under normal circumstances, a relatively small amount of the intact ester is absorbed into the blood through the lungs. The subsequent metabolism will follow that for acrylic acid, and involves metabolism to carbon dioxide via the propionate degradation pathway (acrylic acid --> 3-hydroxypropionic acid --> malonyl semialdehyde --> acetyl S CoA --> --> tricarboxylic acid cycle --> --> CO2). Metabolism of methanol proceeds via a catalase peroxidative pathway or alcohol dehydrogenase pathway. Intact methyl acrylate, which reaches the blood, is detoxified by hydrolysis, as well as by conjugation (by Michael addition) with glutathione (GSH) to form thioethers. The conjugates are then converted to mercapturic acids and excreted in the urine. The main conjugate has been identified as N-acetyl-S-(2-carboxyethyl)cysteine. Inhibition of the hydrolytic pathway with carboxylase inhibitor results in increased metabolism via the GSH conjugation route (Silver 1981, Miller 1981). There is no evidence to suggest that the vinyl moiety undergoes epoxidation in vivo (Delbressine 1981).
Discussion on absorption rate:
Administration of 14C-methyl acrylate to the skin of guinea pigs under occlusive conditions led to severe irritation, i.e. edema and necrosis, confirmed histologically. The test compound penetrated slowly through epidermis and dermis. A large part of the labeled acrylate was retained in the dermis (Seutter and Rijntjes, 1981).
Autoradiography showed that metabolism of a locally administered dose was practically limited to the skin in the first 24 h; subsequently, labeled material was transported by the blood to the kidneys and concentrated in the bladder, whereas other organs showed a slowly rising concentration (Delbressine, 1979).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.